AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹196 Cr | ₹174 Cr | ₹170 Cr | ₹197 Cr | ₹164 Cr |
What is the latest Revenue of AMBALAL SARABHAI ENTERPRISES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹196 Cr |
| Mar2024 | ₹174 Cr |
| Mar2023 | ₹170 Cr |
| Mar2022 | ₹197 Cr |
| Mar2021 | ₹164 Cr |
How is Revenue of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹196 Cr | 13.03 | |
| Mar2024 | ₹174 Cr | 1.93 | |
| Mar2023 | ₹170 Cr | -13.45 | |
| Mar2022 | ₹197 Cr | 20.23 | |
| Mar2021 | ₹164 Cr | - | |
Compare Revenue of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹202.8 Cr | -2.1% | 0.6% | -32.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,713.0 Cr | -1.4% | -3.2% | -0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,811.0 Cr | -1.9% | -8.7% | 1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,052.0 Cr | -3.5% | -6.6% | 30.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,927.0 Cr | -4% | -8.3% | 6.3% | Stock Analytics | |
| CIPLA | ₹96,602.7 Cr | -1.9% | -11.9% | -19% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -2.1% |
0.6% |
-32.8% |
| SENSEX | 0.6% |
-11.1% |
-6.2% |
You may also like the below Video Courses